ANTHEMBiotechnology
Anthem Biosciences Limited — PE Ratio & Valuation Analysis
₹656.25
+5.12%
Current P/E79.93xPrice to earnings
Industry P/E51.82xSector average
4Y Avg P/E81.1x1.4% below avg
⚠️
54.2% Premium to Industry
ANTHEM P/E 79.93x vs sector avg 51.82x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.04 | ₹652 | 81.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Anthem Biosciences Limited Valuation
Anthem Biosciences Limited (ANTHEM) currently trades at 79.93x earnings. The Biotechnology sector average PE is 51.82x. ANTHEM commands a premium, reflecting high growth expectations. Historically, ANTHEM has traded at an average PE of 81.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
20.83%
Dividend Yield
0.00%
More on Anthem Biosciences Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.